User profiles for "author:Bożena Cybulska-Stopa"
Bożena Cybulska-StopaNarodowy Instytut Onkologii (NIO) Verified email at vp.pl Cited by 479 |
Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
G Kamińska-Winciorek, B Cybulska-Stopa… - … in Dermatology and …, 2019 - termedia.pl
The introduction of immunotherapy into the treatment of cancer patients has revolutionised
the oncological approach and significantly improved patient survival. The key drugs are …
the oncological approach and significantly improved patient survival. The key drugs are …
A practical approach to the 2022 ESC cardio-oncology guidelines: Comments by a team of experts–cardiologists and oncologists
P Leszek, A Klotzka, S Bartuś… - Polish Heart …, 2023 - journals.viamedica.pl
The 2022 European Society of Cardiology (ESC) guidelines [1] are a comprehensive
document, prepared jointly by experts in cardiology and oncology. In the case of oncology …
document, prepared jointly by experts in cardiology and oncology. In the case of oncology …
[HTML][HTML] Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective …
P Rutkowski, A Indini, M De Luca, B Merelli… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Obesity is a risk factor for malignancy; however, its prognostic role in patients
with metastatic melanoma is controversial. We aim to investigate the prognostic role of body …
with metastatic melanoma is controversial. We aim to investigate the prognostic role of body …
Cutaneous melanoma
P Rutkowski, PJ Wysocki… - Oncology in clinical …, 2020 - journals.viamedica.pl
According to the authors and editors, this report contains the most justified principles of
diagnostic and therapeutic procedures prepared considering the scientific value of evidence …
diagnostic and therapeutic procedures prepared considering the scientific value of evidence …
Expert recommendations on diagnostic-therapeutic management of melanoma patients
P Rutkowski, PJ Wysocki, K Kozak… - Oncology in Clinical …, 2022 - journals.viamedica.pl
According to the authors and editors, this report contains the best justified principles of
diagnostic and therapeutic procedures prepared on the basis of the scientific value of …
diagnostic and therapeutic procedures prepared on the basis of the scientific value of …
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
B Cybulska-Stopa, I Ługowska… - … in Dermatology and …, 2019 - termedia.pl
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma:
a multicentre study Page 1 Advances in Dermatology and Allergology 5, October / 2019 566 This …
a multicentre study Page 1 Advances in Dermatology and Allergology 5, October / 2019 566 This …
[HTML][HTML] Multimodal treatment of advanced mucosal melanoma in the era of modern immunotherapy
Simple Summary Immunotherapy revolutionized the treatment of cutaneous melanoma and
greatly improved treatment outcomes in this group of patients. Mucosal melanoma is a rare …
greatly improved treatment outcomes in this group of patients. Mucosal melanoma is a rare …
Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients-Real world evidence
B Cybulska-Stopa, P Rogala, AM Czarnecka… - Advances in Medical …, 2020 - Elsevier
Purpose Immunotherapy has become a standard treatment option for patients with
metastatic melanoma, and the use of checkpoint inhibitors significantly improves the …
metastatic melanoma, and the use of checkpoint inhibitors significantly improves the …
Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment
B Cybulska-Stopa, K Piejko, K Ostaszewski… - Melanoma …, 2023 - journals.lww.com
Pembrolizumab and nivolumab (anty-PD-1 antibody) are commonly used for the treatment of
melanoma patients. However, their efficacy and safety have never been directly compared …
melanoma patients. However, their efficacy and safety have never been directly compared …
[HTML][HTML] Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World …
J Placzke, M Rosińska, P Sobczuk, M Ziętek… - Cancers, 2023 - mdpi.com
Simple Summary Performing this real-world analysis, we intended to see if postoperative
(adjuvant) systemic treatment outcomes in a Polish melanoma patient population are …
(adjuvant) systemic treatment outcomes in a Polish melanoma patient population are …